24:[["$","$L25","section-0",{"title":"TRI in the News","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Irina_resources-banner-e1731981783822-a.jpg","headerVariant":"inner page header","currentURI":"/resources/news/","breadcrumbData":{"page":{"__typename":"Page","title":"News","parent":{"__typename":"HierarchicalContentNodeToParentContentNodeConnectionEdge","node":{"__typename":"Page","uri":"/about/","title":"About"}}},"homepage":{"__typename":"Page","uri":"/","title":"TRI"},"resourceParentPage":{"__typename":"Page","title":"Get Involved","uri":"/resources/"},"facilityParentPage":{"__typename":"Page","title":"Facilities","uri":"/facilities/"},"equipment":null},"pageMenu":{"menu":{"__typename":"Menu","count":8,"menuItems":{"__typename":"MenuToMenuItemConnection","nodes":[{"__typename":"MenuItem","label":"Get Involved","uri":"/get-involved/"},{"__typename":"MenuItem","label":"Engage","uri":"/get-involved/engage/"},{"__typename":"MenuItem","label":"TRI Foundation","uri":"/get-involved/tri-foundation/"},{"__typename":"MenuItem","label":"What’s On","uri":"/events/"},{"__typename":"MenuItem","label":"Health Consumers","uri":"/get-involved/health-consumers/"},{"__typename":"MenuItem","label":"SPARQ-ed","uri":"/get-involved/sparq-ed/"},{"__typename":"MenuItem","label":"Training and Resources","uri":"/get-involved/education-and-training/"},{"__typename":"MenuItem","label":"Grants and Funding","uri":"/get-involved/grants-and-funding/"}]}}},"newsDate":""}],["$","$L26","section-2",{"rows":[{"node":["$","$L27","stack-0",{"tileStyle":"style 2","blockTitle":"","blockBody":"","textAlign":"right","textAlignBottom":false,"title":"\"Shifting the dial\"","tags":"TRI News","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Maher-Gandhi.jpg","body":"

New TRI CEO Professor Maher Gandhi has outlined ambitions for in-house clinical trials, translational manufacturing and working with industry.

He has taken up his new role this month, saying it is a marvellous opportunity to work with our partners to build something that is greater than the sum of its parts.

\n","enableButton":true,"buttonText":"","buttonColor":"$undefined","link":{"__typename":"AcfLink","url":"https://www.youtube.com/watch?v=NjBnvaSO-ko","title":"","target":"_blank"},"videoTile":false,"videoLink":"/","enableSubscriptionBox":false,"subBoxTitle":"","gravityFormId":"$undefined"}],"backgroundColor":"$undefined"},{"node":["$","$L27","stack-1",{"tileStyle":"style 2","blockTitle":"","blockBody":"","textAlign":"right","textAlignBottom":false,"title":"cGMP Translational Manufacturing capability coming soon to TRI","tags":"TRI News","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/1959_1.03_Elevation_R007-copy-2.jpeg","body":"

Discover what is coming in 2026 with the launch of our new translational manufacturing facility located on campus at the Princess Alexandra Hospital.

\n","enableButton":true,"buttonText":"","buttonColor":"$undefined","link":{"__typename":"AcfLink","url":"https://youtu.be/PjubzIM2CZM","title":"","target":"_blank"},"videoTile":false,"videoLink":"/","enableSubscriptionBox":false,"subBoxTitle":"","gravityFormId":"$undefined"}],"backgroundColor":"$undefined"}]}],["$","$L28","section-3",{"variant":"only text","textAlign":"left","title":"Stay informed on the latest news and research with TRI's newsletter.","titleColour":"dark","bodyText":"","imageUrl":"","buttonText":"Subscribe","linkType":"link","buttonLink":{"target":"_blank","url":"https://app.vision6.com.au/em/forms/subscribe.php?db=883491&s=955989&a=87704&k=BmWVvas4lnNZv7heAMH--C70JcS3u3J13ia7q_CW8N4","title":"$undefined"},"formId":"$undefined","buttonColor":"accent","ctaLinks":[],"backgroundColor":"grey"}],["$","$L29","section-4",{"layout":"grid","sourceType":"category","multiCategory":false,"title":"News","titleColor":"accent","body":"

Follow the latest translational research news and read about the breakthroughs with global impact occurring at TRI.

\n","backgroundColor":"white","enableButton":false,"button":{"url":"","title":"","target":""},"buttonText":"","buttonColour":"$undefined","tiles":[{"title":"Tuberculosis overtaking Covid as most deadly infectious disease","body":"

Researchers based at TRI, clinicians from the adjoining Princess Alexandra Hospital and patients are collaborating to fight TB.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/UQ-Prof-Antje-Blumenthal.jpg","link":"/resource/tb-most-deadly/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Infectious disease","color":"accent"}]},{"title":"UQ biotech innovation partnership forges a second startup","body":"

UQ’s UniQuest and biotech company Molecule to Medicine have launched a startup focused on developing anti-inflammatory disease medicines.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20210804-news-tuberculosis-and-COVID-Ronacher-image1-scaled.jpg","link":"/resource/uq-biotech-launches-startup/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Immunology","color":"slate"}]},{"title":"Important announcement regarding TRI building closure","body":"

TRI is closing our building as Tropical Cyclone Alfred approaches.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/TRI-Building1500.jpg","link":"/resource/tropical-cyclone-alfred/","categories":[{"label":"News","color":"slate"},{"label":"TRI Announcement","color":"accent"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Inspiring the next generation of researchers","body":"

SPARQ-ed teachers welcome students into their cutting-edge facility, inspiring them to consider STEM subjects and careers.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Sparqed-int-day-of-women-and-girls-2024-scaled.jpg","link":"/resource/inspiring-future-researchers/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"SPARQ-ed","color":"accent"}]},{"title":"AdvanCell’s mission to revolutionise cancer treatment","body":"

A world-first clinical trial for metastatic prostate cancer is underway, using a novel treatment developed by TRI-based AdvanCell.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/AdvanCell-Melissa-and-Amelia-scaled.jpg","link":"/resource/revolutionising-cancer-treatment/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Immunotherapy reduces advanced skin cancer","body":"

University of Queensland researchers have discovered immunotherapy helps reduce advanced sunspots and skin cancers by at least 65 per cent.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/HMBS-immunotherapy-sunspots_NEW-3.jpg","link":"/resource/immunotherapy-reduces-advanced-skin-cancer/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Skin cancer","color":"red"}]},{"title":"New grants for medical breakthroughs","body":"

Seven projects are being supported to progress research in the areas of cancer, a chronic gut disorder and a serious lung condition.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/LINC-Grant-2024-group-shot-featured-image.jpg","link":"/resource/linc-grants-2024/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"People, investment and collaboration key to new TRI CEO’s ambitions","body":"

Professor Maher Gandhi sets his sights on exceptional science and translation, progress to clinical trials and biomedical manufacturing.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Maher-Gandhi2.jpg","link":"/resource/new-tri-ceo-2025/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Bacterially derived small molecule a promising treatment for IBD","body":"

Queensland scientists have secured $2.48 million to revolutionise treatment for inflammatory bowel disease (IBD).

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2025_MR_Jake-Begun-1-1-scaled.jpg","link":"/resource/bacterially-derived-molecule-treatment-for-ibd/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Bowel disease","color":"accent"}]},{"title":"UQ and Vaxxas advance patch-based mRNA COVID-19 vaccine","body":"

UQ and Vaxxas win global prize to advance patch-based mRNA COVID-19 vaccine.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/rectangle-301.png","link":"/resource/uq-vaxxas-covid-19-vaccine/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"Federal Government funding to support six TRI-based projects","body":"

TRI-based researchers have led successful applications in the NHMRC Ideas Grants and Development Grant schemes.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/News_image-NHMRC_2560x1706px.jpg","link":"/resource/nhmrc-december-2024/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Nature may provide the key to beating drug resistant melanoma","body":"

Peptides derived from a crab and a spider core to research findings.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Sonia-and-Aurelie-scaled.jpg","link":"/resource/drug-resistant-melanoma/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Melanoma","color":"accent"}]},{"title":"Humanised immune models advancing therapeutic development","body":"

TRI has a partnership with The Jackson Laboratory to establish Australia’s first immune-humanised preclinical model generation and distribution facility.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024_MR_Prof-Kristen-Radford-TRI-9-scaled.jpg","link":"/resource/human-immune-partnership/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Human Immune Models","color":"mint"}]},{"title":"Developing new cystic fibrosis treatment","body":"

Researchers are determining the feasibility of a clinical trial for a new therapy to help improve the lifespan of people with cystic fibrosis.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/08/Timothy-Wells-Lab_1-scaled.jpg","link":"/resource/fighting-cf-infections/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cystic Fibrosis","color":"mint"}]},{"title":"New CEO for Translational Research Institute","body":"

Eminent cancer researcher and clinician Professor Maher Gandhi has been appointed as the next Chief Executive Officer of TRI.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Maher-Gandhi_news_CEO-TRI_resized.jpg","link":"/resource/new-tri-ceo-2/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Study discovers potential boost for bladder cancer treatment","body":"

Team finds certain cancer cells release a protein that blunts the effectiveness of immune cell, giving them a potential target for new treatments.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Fernando-scaled.jpg","link":"/resource/bladder-cancer-boost/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Transforming healthcare with microbiome research","body":"

TRI-based researchers from QUT are progressing our understanding of the human microbiome and its role in human health and disease.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Gene_Tyson_in-lab-website.jpg","link":"/resource/microbiome-in-health/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Microbiome","color":"slate"},{"label":"Translational Trials","color":"accent"}]},{"title":"Prestigious international award for TRI CEO","body":"

TRI CEO Professor Scott Bell has been recognised for his outstanding contribution to cystic fibrosis with a prestigious international award.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Scott-Bell-receives-European-Cystic-Fibrosis-Award.jpg","link":"/resource/ecfs-award/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cystic Fibrosis","color":"mint"},{"label":"TRI Announcement","color":"accent"}]},{"title":"Parkinson’s research targets gut microbiome","body":"

Researchers based at TRI are developing Parkinson’s disease treatments by targeting the gut microbiome.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/05/20240427_news-parkinson-disease-richard-gordon-image-3-scaled-e1731999362866.jpg","link":"/resource/parkinsons-and-microbiome/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Microbiome","color":"slate"},{"label":"Neuroscience","color":"sky"}]},{"title":"TRI and Vaxxas celebrate major milestone","body":"

Vaxxas has produced its 100th batch of needle‐free vaccine patches at TRI – technology that may soon help protect Australians against infectious diseases.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Tri-Vaxxas-1-e1737592320653.jpg","link":"/resource/tri-and-vaxxas-milestone/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Funding for cancer, liver, brain and pain research","body":"

TRI-based researchers, industry tenants, collaborators and affiliates are sharing in more than $17million in the latest round of National Health and Medical Research Council (NHMRC) funding.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Trio-a-e1737592232412.jpg","link":"/resource/nhmrc-support-may-2024/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Research Support","color":"accent"}]},{"title":"2024 TRI Translation Fellows announced","body":"

The Translational Research Institute (TRI) has awarded four Translation Fellowships to mid-career researchers.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20240430-news-Translation-Fellows-Kemp-image4-e1732482613412.jpg","link":"/resource/2024-translation-fellows/","categories":[{"label":"Grant Stories","color":"slate"},{"label":"News","color":"slate"}],"researchareas":[{"label":"Fellowship","color":"sky"}]},{"title":"Princess Alexandra Hospital home to world first prostate cancer trial","body":"

A radiopharmaceutical company based at TRI is part of a world-first trial of a treatment for difficult-to-treat cancers that have spread in the body.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/05/20240427_news-parkinson-disease-richard-gordon-image-7.jpg","link":"/resource/targeted-alpha-therapy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Translational Trials","color":"accent"}]},{"title":"TRI to farewell Chief Executive","body":"

Respected respiratory physician Professor Scott Bell has announced he will not seek an extension of his five-year tenure as Chief Executive Officer of TRI.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/TRI-ScottBell-19.10.2023-71.jpg","link":"/resource/scott-bell-farewell/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Tech and new skills unlocking cancer’s cellular secrets","body":"

TRI-based researcher Dr Arutha Kulasinghe is combining cancer biology, high-speed imaging, advanced machine learning and artificial intelligence processing power to better understand cancer at a cellular level.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/04/QSBC-Scientific-Director-Dr-Arutha-Kulasingh-and-QSBC-Clinical-Director-Professor-John-Fraser-1-2.jpg","link":"/resource/unlocking-cancers-cellular-secrets/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Translating cancer research for more effective treatments","body":"

Professor Kum Kum Khanna has joined Mater Research, with the aim of developing new treatments, or repurposing FDA-approved medicines, for treatment of aggressive forms of breast and ovarian cancer.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/MR_2024_Tumour-Biology-and-Therapeutics-Research_TRI-Lab-1-hi-res-scaled-e1731995430516.jpg","link":"/resource/better-cancer-treatments/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Boost for deadly ovarian cancer vaccine","body":"

Mater Research is set to spearhead the development of a ground-breaking vaccine to treat ovarian cancer thanks to a $670,000 OCRF (Ovarian Cancer Research Foundation) grant announced today.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20200707-news-cancer-vaccine-Radford-image-resized.jpg","link":"/resource/ovarian-cancer-vaccine-boost/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Ovarian Cancer","color":"accent"}]},{"title":"Australian first: lab grown skin to help burn victims","body":"

Queensland researchers have become the first in Australia to use human stem cells to generate fully functioning skin tissue in a laboratory, a significant step towards better treatments for severe burns and wounds.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/MED-skin-healing-composite-620W.jpg","link":"/resource/lab-grown-skin/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Genomics","color":"mint"}]},{"title":"Pregnancy complications linked to COVID-19","body":"

DNA changes consistent with life-threatening pregnancy complications have been found in the placentas of pregnant women infected by COVID-19, according to researchers from The University of Queensland.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/02/Close-up-of-an-express-antigen-covid-test-negative-result.-Pregnant-woman.jpg","link":"/resource/covid-and-pregnancy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"Nephrologist claims Australia Day Honour","body":"

Professor Carmel Hawley joins the highest ranks in the country with an appointment as a Member of the Order of Australia (AM).

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/carmel-Hawley_clinical-headshot2-scaled.jpg","link":"/resource/carmel-hawley-am-honour/","categories":[{"label":"Awards","color":"slate"},{"label":"News","color":"slate"}],"researchareas":[{"label":"Kidney Medicine","color":"accent"},{"label":"Nephrology","color":"accent"}]},{"title":"New LINC Grants aim to tackle unmet medical need","body":"

Seven projects have secured funding from TRI through the latest LINC grants, to progress research in the areas of cancer, children’s immunity and blood infection.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024_news-LINC-grant-image-1-e1731995570721.jpg","link":"/resource/linc-grants-2023/","categories":[{"label":"Grant Stories","color":"slate"},{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Elderly cancer patients at heart of new frailty intervention study","body":"

The Princess Alexandra Hospital and The University of Queensland Frailty Network have secured funding to support a new study.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/pah-team-secures-cancer-research-grant-for-breakthrough-study-hero.jpg","link":"/resource/cancer-and-frailty/","categories":[{"label":"Grant Stories","color":"slate"},{"label":"News","color":"slate"}],"researchareas":[{"label":"Ageing","color":"accent"},{"label":"Cancer","color":"red"}]},{"title":"Advancing personalised cancer vaccines and therapies","body":"

Immunologist Dr Jazmina Gonzalez Cruz is leading a pioneering research program to identify and design personalised cancer treatments.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2023/09/Jazmina-Gonzalez-Cruz_Team-photo_1-scaled.jpg","link":"/resource/personalised-cancer-therapies/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Immunology","color":"slate"}]},{"title":"Federal funding for TRI-based researchers","body":"

TRI-based researchers from The University of Queensland, Mater Research and Queensland University of Technology are sharing in more than $12million in the latest round of National Health and Medical Research Council (NHMRC) funding.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Fiona-Simpson-e1737592262967.jpg","link":"/resource/nhmrc-funding-december-2023/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Research Support","color":"accent"}]},{"title":"Major genetic study into osteoporosis","body":"

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20231215-news-New-major-genetic-study-into-Osteoporosis-Kemp-image-1.png","link":"/resource/genetics-in-osteoporosis/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Genetics","color":"mint"}]},{"title":"Fighting one of our deadliest cancers","body":"

Mater Researcher Professor John Hooper will share in $1.8 million of funding from PanKind, the Australian Pancreatic Cancer Foundation, to investigate early detection and new treatments for pancreatic cancer.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/JA_Mater_JohnHooper_011-1-scaled.jpg","link":"/resource/fighting-a-deadly-cancer/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"TRI’s new Musculoskeletal Genomics Group","body":"

TRI is home to the new Mater Research Musculoskeletal Genomics Group, with its focus firmly on discovering new therapeutic targets for musculoskeletal disorders.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20231017-news-Musculoskeletal-Genomics-Group-Kemp-image2.jpg","link":"/resource/musculoskeletal-genomics-group/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Genomics","color":"mint"}]},{"title":"Vale Chuck Feeney","body":"

Paying tribute to philanthropist Charles ‘Chuck’ Feeney, who was instrumental in supporting the establishment of major research institutes around South East Queensland – including TRI.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/849x493q70gastrow-feeney.jpg","link":"/resource/vale-chuck-feeney/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Advancing breast cancer research and awareness","body":"

QUT Professor in Breast Cancer Research Rik Thompson leads a TRI-based group aiming to understand the molecular and cellular processes driving breast cancer risk, progression and therapy resistance.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/09/20231009_rik-thompson-headshot-scaled.jpg","link":"/resource/advanicing-breast-cancer-research-and-awareness/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Breast Cancer","color":"red"}]},{"title":"Genes identified for aggressive melanoma","body":"

Researchers from The University of Queensland and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Lab-scientist-biotechnologist-holding-glass-ampoule-phial-with-DNA-strand.jpg","link":"/resource/genes-for-aggressive-melanoma/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Genetics","color":"mint"}]},{"title":"Research could bring better treatment for chronic Inflammation","body":"

TRI-based Mater Researchers have discovered that an immune factor released by white blood cells during infection or inflammation works to suppress the body’s immune response instead of enhancing it.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20191210-news-new-treatment-for-obesity-Hasnaint-image2-scaled.jpg","link":"/resource/chronic-inflammation-research/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Immunology","color":"slate"}]},{"title":"New target to beat cancer drug resistance","body":"

The University of Queensland researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumour regrowth in cancer patients.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2023/09/Results-of-drug-resistant-in-the-laboratory-room.jpg","link":"/resource/beating-cancer-drug-resistance/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"National kidney disease trial starts recruiting","body":"

Patient recruitment is underway for a University of Queensland-led clinical trial to test the effectiveness of a diabetes drug to slow the progression of polycystic kidney disease.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2023/08/Chronic-kidney-disease.jpg","link":"/resource/kidney-disease-trial/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Kidney disease","color":"accent"}]},{"title":"Perfecting medicinal lotions","body":"

Researchers at TRI are helping scientists and industry develop the most effective formulations and methods for delivering therapeutics via the skin.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/YM_team-photo_2023_1-scaled.jpg","link":"/resource/perfecting-medicinal-lotions/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Therapeutic","color":"accent"}]},{"title":"New funding for lymphoma research","body":"

TRI-based researcher Dr Joshua Tobin, a member of Mater Research’s Blood Cancer Group led by Professor Maher Gandhi, has recently been awarded $150,000 in funding to further his research into lymphoma.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20230807-lymphoma-research-Tobin-image-2-e1737592097275.jpg","link":"/resource/lymphoma-research-funding/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Study into new osteoporosis fracture therapy","body":"

TRI-based scientists from Mater Research and The University of Queensland have recently identified a potential treatment to enhance the healing of fractures among osteoporosis sufferers.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20230804-news-therapy-to-heal-osteoporosis-fractures-Pettit-image-1.png","link":"/resource/osteoporosis-fractures/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Osteoporosis","color":"accent"}]},{"title":"Tackling rising inflammatory bowel disease epidemic","body":"

A joint research collaboration between the TRI and Princess Alexandra Hospital is investigating factors at play with inflammatory bowel diseases.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/research-key-to-treating-painful-condition-hero.jpg","link":"/resource/tackling-rising-ibd-rates/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Microbiology","color":"accent"}]},{"title":"Smarter AI for skin cancer care","body":"

Researchers from The University of Queensland have supported a study to improve the performance of an artificial intelligence (AI) model in skin cancer diagnosis and management.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/DSC04024-1-scaled.jpg","link":"/resource/ai-for-skin-cancer/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Skin cancer","color":"red"}]},{"title":"Studying rising rates of Type 1 diabetes in children","body":"

Professor Jo Forbes from Mater Research says Type 1 diabetes in children is twice as common now than it was 20 years ago.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20230714-news-Type-1-diabetes-in-children-Jo-Forbes-image1-scaled-e1732245169894.jpg","link":"/resource/diabetes-in-children/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Diabetes","color":"mint"}]},{"title":"TRI announces 2023 translation fellowships","body":"

TRI has awarded four Translation Fellowships to early and mid-career researchers. The 12-month Fellowships, valued at $20,000 each, were launched in 2023 as part of TRI’s flagship Translation Pathways program.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20230629_news-TRI-translation-fellowships.jpg","link":"/resource/2023-translation-fellowships/","categories":[{"label":"Grant Stories","color":"slate"},{"label":"News","color":"slate"}],"researchareas":[{"label":"Translational Research","color":"red"}]},{"title":"Seed funding for translational clinical collaborations","body":"

TRI and its hospital partners have jointly awarded new research grants to drive new collaborations between clinicians and scientists.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20230529_news_medical-research-seed-funding.jpg","link":"/resource/translational-seed-funding/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Translational Research","color":"red"}]},{"title":"CSIRO and TRI award grants to fast-track digital healthcare solutions","body":"

TRI and the Australia e-Health Research Centre at CSIRO have jointly awarded $300,000 to innovative projects aimed at solving a healthcare challenge.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20230529_news-TRI_CSIRO_Grant2.jpg","link":"/resource/csiro-tri-grants/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Translational Research","color":"red"}]},{"title":"Collaboration yields world-first nerve repair surgery","body":"

The first patient of an ongoing clinical trial has recovered well following world-first sutureless nerve repair surgery.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/004-Tempus-Media-ACCISS-High-Res-e1737592397764.jpg","link":"/resource/nerve-repair-surgery/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Translational Trials","color":"accent"}]},{"title":"New sleep findings for children with autism","body":"

A new study has identified that fat molecules contribute to sleep disturbances in children diagnosed with autism, with results now published in Nature Medicine.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20230421-news-sleep-problems-among-children-with-autism-Yap-image1_resized.jpg","link":"/resource/sleep-and-autism/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Autism","color":"sky"}]},{"title":"Liver damage could be a major outcome of severe COVID-19","body":"

Liver damage could be a major outcome of severe COVID-19 infection in a landmark study involving TRI-based researchers.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2023/04/20230418_news-liver-damage-jyotsna-batra-image-1-scaled.jpg","link":"/resource/liver-damage-covid-19-infection/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"Boost to study into better healthcare for our vulnerable elderly","body":"

Professor Ruth Hubbard is celebrating, after being awarded a Metro South Health Research Project Grant.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20230413-image-1-e1731282436492.jpg","link":"/resource/study-for-vulnerable-elderly/","categories":[{"label":"Awards","color":"slate"},{"label":"News","color":"slate"}],"researchareas":[{"label":"Ageing","color":"accent"}]},{"title":"Developing precision treatment to boost cancer patient immunity","body":"

Scientists are harnessing a new class of pharmaceutical compounds to develop a drug to boost the immune system’s ability to fight cancer.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2023/03/20230322_news-cancer-immunotherapy-Laura-Croft-image-4-scaled.jpg","link":"/resource/precision-cancer-treatment/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Immunology","color":"slate"}]},{"title":"Boosting antibody production key to tackling COVID variants","body":"

Findings from COVID-19 variant study may help in developing strategies for improved vaccinations.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Dr-Chen-Zhian-horizontal.jpg","link":"/resource/tackling-covid-variants/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"Study to explore tablet-based treatment for ovarian cancer","body":"

Potential tablet treatment could be more effective and have fewer side effects than current chemotherapy.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20230208-news-treatment-for-ovarian-cancer-gabrielli-image-1-e1728968037437.jpg","link":"/resource/ovarian-cancer-tablet/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Ovarian Cancer","color":"accent"}]},{"title":"Potential Parkinson’s breakthrough: blood platelets hold genetic clues","body":"

A Mater Research study’s findings have been published in international journal Cell Genomics.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20230203-news-Potential-Parkinsons-breakthrough-Gratten-image2.jpg","link":"/resource/potential-parkinsons-breakthrough/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Genetics","color":"mint"},{"label":"Neuroscience","color":"sky"}]},{"title":"New diagnostic could improve outcomes for oesophageal cancer","body":"

Scientists and clinicians have identified biological markers which could be used in a simple blood test to help improve survival rates for cancer patients.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Vanessa-Bonazzi_Lab-3_Nov-2022-scaled-e1728352158835.jpg","link":"/resource/oesophageal-cancer-diagnostic/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Methane ‘gobbling’ microorganism is a shape shifter: Nature Microbiology","body":"

A microorganism that helps reduce the release of the greenhouse gas methane into the atmosphere has been found to be a ‘shape shifter’.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2023/01/20230113_news-methan-oxidation-simon-macllroy-image-1.jpg","link":"/resource/methane-gobbling-microorganism/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Microbiology","color":"accent"}]},{"title":"New study to fight world’s deadliest infectious disease: Tuberculosis","body":"

Mater Research is aiming to unlock the cause of severe tuberculosis, which is once again the world’s deadliest infectious disease.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20210804-news-tuberculosis-and-COVID-Ronacher-image1-scaled.jpg","link":"/resource/severe-tb-cause/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Infectious disease","color":"accent"}]},{"title":"Imaging tech could give better breast cancer risk estimation","body":"

Australian women could better gauge their breast cancer risk through new imaging technology, without radiation that comes with mammography.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/12/20221220_news-breast-cancer-rik-thompson-image-1.jpg","link":"/resource/breast-cancer-risk/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Breast Cancer","color":"red"}]},{"title":"TRI turns 10","body":"

TRI has marked 10 years since the first staff from research partners The University of Queensland, QUT, Mater Research and Metro South Health began to move into the building.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/12/20221201_news-TRI-turns-10-image-1-scaled.jpg","link":"/resource/tri-turns-10/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"New treatment for COVID-19 targets cholesterol receptors","body":"

A new study has identified a key cause of severe COVID-19 infections and paves the way for a new treatment of the disease.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20210804-news-tuberculosis-and-COVID-Ronacher-image1-scaled.jpg","link":"/resource/covid-19-cause/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"A cream could treat killer cancer in organ transplant patients","body":"

Research and pilot study results show three-to-four-fold reduction in skin cancers in patients using the cream.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Prof.-Kiarash-1-scaled.jpg","link":"/resource/cream-for-killer-cancer-2/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"UQ ‘Frazer Institute’ honours founding TRI CEO","body":"

The University of Queensland has recognised the contribution of Emeritus Professor Ian Frazer by renaming the UQ Diamantina Institute in his honour.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Professor-Ian-Frazer-laboratory-scaled.jpg","link":"/resource/honouring-ian-frazer/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"UQ Announcement","color":"accent"}]},{"title":"Study reveals how COVID-19 damages the heart ","body":"

TRI-based researchers from The University of Queensland have found COVID-19 can damage the DNA in cardiac tissue.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/10/COVID-19-viruses-affecting-the-heart-conceptual-3D-illustration.jpg","link":"/resource/covid-heart-damage/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"Could there soon be a nasal spray to help prevent COVID infection?","body":"

The possibility of a mouthwash or nasal spray to prevent or reduce the spread of the COVID-19 infections is being investigated by TRI-based QUT scientists.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/09/20220919_news-COVID-infection-RikThompson-image-2.jpg","link":"/resource/covid-nasal-spray/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"New therapies turning off energy for prostate cancer cells","body":"

QUT researchers based at TRI are developing new drugs to shut down the energy pathways essential to prostate cancer cells’ survival.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/09/20220915_news-prostate-cancer-jennifer-gunter-image-1-scaled.jpg","link":"/resource/prostate-cancer-energy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Prostate Cancer","color":"red"}]},{"title":"Kelsie determined to beat melanoma after 14 operations ","body":"

Brisbane resident is sharing her story to raise awareness that melanoma can affect all ages.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20220913-news-Kelsie-determined-to-beat-melanoma-Gabrielli-image-1.jpg","link":"/resource/kelsie-fights-melanoma/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Melanoma","color":"accent"}]},{"title":"Contributing to report charting preparedness for future pandemics","body":"

TRI CEO Professor Scott Bell has contributed to a CSIRO report that sets out how Australia can improve its resilience to future pandemics.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/08/20220830_CSIRO-report-Scott-Bell-image-2.jpg","link":"/resource/future-pandemic-preparedness/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Covid-19","color":"accent"}]},{"title":"World-first study finds link between exercise and improved asthma","body":"

Moderate exercise, as opposed to vigorous levels, has been found to reduce airway inflammation in people with asthma.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/John-Upham-e1739861458103.jpg","link":"/resource/exercise-and-asthma/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Asthma","color":"accent"}]},{"title":"TRI-based UQ researchers awarded more than $1.5 million in funding","body":"

Two TRI-based research groups have secured funding to develop new treatments for type 1 diabetes and cancer.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20220802-image-1-e1741312946576.jpg","link":"/resource/cureator-scheme-funding/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Type 1 Diabetes","color":"accent"}]},{"title":"Vaccine manufacturing facility to be built with $60million in funding","body":"

A medical manufacturing facility, equipped to produce promising drugs and vaccines for clinical trials, will be built with $60 million from the Queensland Government.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20220616_Vaccine-Manufacturing-QLD-Funding-image-3-e1737438152794.jpg","link":"/resource/translational-manufacturing-funding/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Addressing painful spinal injury complication in trauma victims","body":"

Researchers identify key signalling processes leading to neurogenic heterotopic ossification.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20220411-news-spinal-injury-complication-Levesque-image1.png","link":"/resource/nho-research-breakthrough/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Spinal cord injury","color":"accent"}]},{"title":"Better patient outcomes the focus of new LINC grants","body":"

TRI, Metro South Health and Mater Research have announced the recipients of almost $400,000 in research grant funding through their jointly funded LINC scheme.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20220329_news-research-LINC-grant-image1-resized.jpg","link":"/resource/linc-grants-2022/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Translational Research","color":"red"}]},{"title":"Modified dietary fibre shows promise in helping manage Type 1 diabetes","body":"

Dietary supplement found to promote gut health and a strong immune system.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2022/01/Diabetic-senior-man-on-wheelchair-checking-blood-sugar-level.jpg","link":"/resource/dietary-fibre-in-diabetes/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Type 1 Diabetes","color":"accent"}]},{"title":"New discovery shows how to disarm deadly listeria bacteria","body":"

Researchers have unlocked a way of fighting listeria infections, which can cause severe illness in pregnancy and people with compromised immune systems.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Listeria.jpg","link":"/resource/disarming-listeria-bacteria/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Immunology","color":"slate"}]},{"title":"Liver disease treatment get $1.3M international boost","body":"

New study investigates early-stage liver inflammation, which is difficult to diagnose and typically asymptomatic.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20191210-news-new-treatment-for-obesity-Hasnaint-image2-scaled.jpg","link":"/resource/liver-disease-boost/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Liver disease","color":"sky"}]},{"title":"Pre-diabetes linked to worse tuberculosis and COVID-19 outcomes","body":"

Study finds pre-diabetes increases the risk of more severe inflammation in the lungs after infection.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20210804-news-tuberculosis-and-COVID-Ronacher-image1-scaled.jpg","link":"/resource/pre-diabetes-and-tb/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Diabetes","color":"mint"}]},{"title":"New treatment targeting leading causes of blindness","body":"

Research focusing on better options for age-related macular degeneration and retinal neovascularisation linked to diabetes.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Eye.jpg","link":"/resource/causes-of-blindness/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Clinical Research","color":"sky"}]},{"title":"Hormone therapy may fuel bone cancer in prostate patients: study","body":"

Anti-androgen therapy used to treat patients with advanced prostate cancer may be fuelling bone cancer spread.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2021/07/20210705-news-prostate-cancer-Natalie-Bock-image2.jpg","link":"/resource/bone-prostate-cancer/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Prostate Cancer","color":"red"}]},{"title":"Childhood sugar overload: a recipe for long-term problems","body":"

Children who consume too much sugar could be at greater risk of becoming obese, hyperactive and cognitively impaired as adults, a study has found.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2021/06/20191213-news-sugar-comsumption-selena-bartlett-image-2-scaled.jpeg","link":"/resource/childhood-sugar-overload/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Neuroscience","color":"sky"}]},{"title":"Breakthrough discovery: Immune cells that can stop melanoma growth","body":"

Researchers find cells can halt the rapid development of melanoma lesions and can potentially be used as protection in immunotherapy.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2021/06/Gabrielle-Belz_Lab.jpg","link":"/resource/melanoma-research-breakthrough/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Immunology","color":"slate"}]},{"title":"Metabolic hormone key to boosting vaccine effectiveness","body":"

TRI-based researchers say they can now identify people at risk of not generating an antibody response after vaccination.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20210531-image-1-scaled.jpg","link":"/resource/boosting-vaccine-effectiveness/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Genetics","color":"mint"},{"label":"Immunology","color":"slate"}]},{"title":"Gene therapy advances show promise in scar and burn treatment","body":"

Research has the potential to benefit people who’ve had knee or hip surgeries, melanomas removed or suffered burns.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/Prof.-Kiarash-1-scaled.jpg","link":"/resource/scars-and-burns/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Genetics","color":"mint"}]},{"title":"New immunotherapy aims to conquer breast cancer","body":"

Research has the potential to impact those patients who have failed conventional therapies and have a worse overall prognosis.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/DSC03828-scaled.jpg","link":"/resource/breast-cancer-immunotherapy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Breast Cancer","color":"red"},{"label":"Cancer","color":"red"}]},{"title":"Research challenges established Alzheimer’s Disease theories","body":"

New research opportunities open up to better understand the disease.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/human-brain_webpage-banner-e1728094912608.jpg","link":"/resource/alzheimers-theory-revised/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Neuroscience","color":"sky"}]},{"title":"Skin cancer shield developed for transplant patients","body":"

The world-first treatment being developed by TRI-based researchers from The University of Queensland is the only drug of its type that could prevent the incidence of skin cancers for transplant patients.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20201123-image-2.jpg","link":"/resource/cancer-shield-for-transplant-patients/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"Promising cancer vaccine enters preclinical phase","body":"

TRI-based researchers have developed a new cancer vaccine that aims to minimise potential side effects.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20200707-news-cancer-vaccine-Radford-image2.jpg","link":"/resource/promising-cancer-vaccine/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"}]},{"title":"New ovarian cancer diagnostic going to trial","body":"

TRI-based researchers from The University of Queensland have unlocked a way of fighting Listeria infections, which can cause severe illness in pregnant women and people with compromised immune systems.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2021/07/20210705-news-prostate-cancer-Natalie-Bock-image1-scaled.jpg","link":"/resource/new-ovarian-cancer-diagnostic-going-to-trial/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Ovarian Cancer","color":"accent"}]},{"title":"New hope in ovarian cancer detection","body":"

TRI-based researchers have received almost $1.9 million in vital funding from the Australian Government for a trial of a new diagnostic.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20200416-news-ovarian-cancer-therapy-Hooper-image1.jpg","link":"/resource/ovarian-cancer-detection/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cancer","color":"red"},{"label":"Ovarian Cancer","color":"accent"}]},{"title":"New drug to beat chemo resistance in ovarian cancer","body":"

Scientists have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows cell growth.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/JA_Mater_JohnHooper_022-scaled-e1734668350692.jpg","link":"/resource/resistant-ovarian-cancer/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Ovarian Cancer","color":"accent"}]},{"title":"New drug approach may boost ovarian cancer therapy","body":"

Scientists from Mater Research have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows cell growth.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/JA_Mater_JohnHooper_011-1-scaled.jpg","link":"/resource/boosting-ovarian-cancer-therapy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Ovarian Cancer","color":"accent"}]},{"title":"Blood pressure medication could combat alcohol dependence","body":"

A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain’s ability to grow new cells, QUT researchers based at TRI have found.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2019/12/20191213-blood-pressure-selena-bartlett-image-2-e1737591039728.png","link":"/resource/blood-pressure-medication-alcohol-dependence/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Neuroscience","color":"sky"}]},{"title":"Targeting new treatment for obesity-related liver disease","body":"

A new spin-out from The University of Queensland will develop a novel therapy for the growing problem of obesity-related liver disease.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2024/10/20191210-news-new-treatment-for-obesity-Hasnaint-image2-scaled.jpg","link":"/resource/obesity-related-liver-disease/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Liver disease","color":"sky"}]},{"title":"Team discovers promising approach for blood cancer immunotherapy","body":"

Researchers discover a new mechanism used by the Epstein-Barr virus to evade the immune system.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Prof-Maher-Gandhi_10y-achievements.jpg","link":"/resource/blood-cancer-immunotherapy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Blood cancer","color":"red"},{"label":"Cancer","color":"red"}]},{"title":"Jyotsna Batra wins Young Tall Poppy science award","body":"

QUT scientist recognised for outstanding research and academic achievement, as well as excellence in communication and community engagement.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/2019/09/20190917_Young-Tall-Poppy-Award_image-4-scaled.jpg","link":"/resource/batra-tall-poppy/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Prostate Cancer","color":"red"}]}]}],["$","$L29","section-5",{"layout":"carousel","sourceType":"individual","multiCategory":false,"title":"Industry news","titleColor":"dark","body":"","backgroundColor":"grey","enableButton":true,"button":{"url":"https://tri.edu.au/industry/","title":"Industry","target":"_blank"},"buttonText":"View all industry news","buttonColour":"transparent","tiles":[{"title":"TRI and Vaxxas celebrate major milestone","body":"

Vaxxas has produced its 100th batch of needle‐free vaccine patches at TRI – technology that may soon help protect Australians against infectious diseases.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Tri-Vaxxas-1-e1737592320653.jpg","link":"/resource/tri-and-vaxxas-milestone/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"Prestigious international award for TRI CEO","body":"

TRI CEO Professor Scott Bell has been recognised for his outstanding contribution to cystic fibrosis with a prestigious international award.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/Scott-Bell-receives-European-Cystic-Fibrosis-Award.jpg","link":"/resource/ecfs-award/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"Cystic Fibrosis","color":"mint"},{"label":"TRI Announcement","color":"accent"}]},{"title":"Vaccine manufacturing facility to be built with $60million in funding","body":"

A medical manufacturing facility, equipped to produce promising drugs and vaccines for clinical trials, will be built with $60 million from the Queensland Government.

\n","imageUrl":"https://backend.tri.edu.au/wp-content/uploads/20220616_Vaccine-Manufacturing-QLD-Funding-image-3-e1737438152794.jpg","link":"/resource/translational-manufacturing-funding/","categories":[{"label":"News","color":"slate"}],"researchareas":[{"label":"TRI Announcement","color":"accent"}]},{"title":"TRI’s new Musculoskeletal Genomics Group","body":"

TRI is home to the new Mater Research Musculoskeletal Genomics Group, with its focus firmly on discovering new therapeutic targets for musculoskeletal disorders.

Researchers at TRI are helping scientists and industry develop the most effective formulations and methods for delivering therapeutics via the skin.

TRI CEO Professor Scott Bell has contributed to a CSIRO report that sets out how Australia can improve its resilience to future pandemics.